ClearPoint Neuro, Inc. (CLPT) Misses Q2 EPS by 16c

ClearPoint Neuro, Inc. (NASDAQ: CLPT) reported Q2 EPS of ($0.35), $0.16 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $5.2 million versus the consensus estimate of $5.08 million.

GUIDANCE:

ClearPoint Neuro, Inc. sees FY2022 revenue of $21-22 million, versus the consensus of $21.2 million.

For earnings history and earnings-related data on ClearPoint Neuro, Inc. (CLPT) click here.

You May Also Be Interested In

• Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
• SunPower (SPWR) determined prior financial statements should no longer be relied upon
• Philip Morris International (PM) Tops Q1 EPS by 9c; raises guidance